Ikena Oncology Inc
General ticker "IKNA" information:
- Sector: Health Care
- Industry: Pharmaceuticals
- Capitalization: $80.4M
Ikena Oncology Inc follows the US Stock Market performance with the rate: 22.7%.
Estimated limits based on current volatility of 5.4%: low 1.55$, high 1.73$
Factors to consider:
- Price in estimated range
- Earnings for 9 months up through Q3 exceed our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2023-12-31 to 2025-12-30
- 2023-12-31 to 2024-12-30 estimated range: [1.12$, 3.19$]
- 2024-12-30 to 2025-12-30 estimated range: [1.32$, 3.42$]
Financial Metrics affecting the IKNA estimates:
- Negative: Non-GAAP EPS, $ of -1.64 <= 0.10
- Negative: Operating profit margin, % of -89.17 <= 1.03
- Negative: Operating cash flow per share per price, % of -51.46 <= 2.35
- Negative: negative Net income
- Positive: Industry inventory ratio change (median), % of -2.41 <= -0.39
- Positive: Interest expense per share, $ of 0 <= 0
- Negative: Industry operating profit margin (median), % of -70.04 <= 2.14
Short-term IKNA quotes
Long-term IKNA plot with estimates
Financial data
YTD | 2021-12-31 | 2022-12-31 | 2023-12-31 |
---|---|---|---|
Operating Revenue | $30.98MM | $15.62MM | $9.16MM |
Operating Expenses | $65.12MM | $86.52MM | $84.58MM |
Operating Income | $-34.14MM | $-70.90MM | $-75.42MM |
Non-Operating Income | $0.05MM | $4.28MM | $7.09MM |
Interest Expense | $0.00MM | $2.15MM | $0.00MM |
R&D Expense | $47.11MM | $64.32MM | $59.65MM |
Income(Loss) | $-34.09MM | $-66.63MM | $-68.33MM |
Taxes | $0.00MM | $0.00MM | $-0.16MM |
Profit(Loss) | $-34.09MM | $-66.63MM | $-68.17MM |
Stockholders Equity | $207.88MM | $146.97MM | $169.76MM |
Assets | $247.88MM | $172.26MM | $192.09MM |
Operating Cash Flow | $-60.25MM | $-74.11MM | $-79.74MM |
Capital expenditure | $1.76MM | $1.43MM | $0.41MM |
Investing Cash Flow | $-1.76MM | $-99.28MM | $64.14MM |
Financing Cash Flow | $131.74MM | $1.09MM | $75.98MM |
Earnings Per Share* | $-0.95 | $-1.84 | $-1.63 |
* EPS are Split Adjusted, recent splits may be reflected with a delay.